Privacy Statement   Terms & Conditions   Sitemap  
  Diseases   Research   About us  
Clinical Development Product Pipeline How Vaccines work Glossary Events
 
Clinical Development

  Clinical Development

Vaccines are one of the greatest achievements of biomedical science and public health. Routine immunization has drastically reduced the incidence of preventable infectious diseases globally. Through vaccination it was possible to eradicate smallpox entirely, and cases of diseases such as polio, pertussis and measles are at an all-time low. Immunizations are among the most effective and safest of all health tools. As the use of vaccines has become more common and widespread (many governments have even made vaccination mandatory), some people tend to focus more on the risks associated with vaccination than the consequences of preventable diseases like meningococcal or streptococcal infections or influenza.

Extremely high safety standards have been placed on vaccines mainly due to the fact that most vaccines are given to healthy people, many of whom are children. Before a vaccine is approved for licensure, it must undergo extensive tests in the laboratory and in humans.


 » Printversion

 
 
  » find


 

Baxter Receives EMEA Positive Opinion for CELVAPAN, the First Cell Culture-based Pandemic Flu Vaccine
» read more

The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxter's Cell-Based Pandemic, Avian Flu Vaccine
» read more

U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCīs DVC and Baxter
» read more

 
Baxter Vaccines Industriestrasse 67, A-1221 Wien, Tel: +43-1-20100,